Mycobacterium mucogenicum Springer et al. (ATCC® 49651)

Strain Designations: MO135 [CDC 87-753]  /  Type Strain: no  /  Biosafety Level: 2

Strain Designations MO135 [CDC 87-753]
Application
Characterization
Isolation
Post-injection site abscess, Texas
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain no
Name of Depositor RJ Wallace
Chain of Custody
ATCC <-- RJ Wallace <-- TS McHorse
Isolation
Post-injection site abscess, Texas
References

Band JD, et al. Peritonitis due to a Mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis 145: 9-17, 1982. PubMed: 7054321

Springer B, et al. Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. Int J Syst Bacteriol 45: 262-267, 1995. PubMed: 7537060

Wallace RJ Jr., et al. Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism. J Clin Microbiol 31: 3231-3239, 1993. PubMed: 8308116

Cross References

Nucleotide (GenBank) : X80772 Mycobacterium Chelonae-like organism 16S rRNA gene.